Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 4 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Interferon-γ couples CD8+ T cell avidity and differentiation during infection.
Nat Commun. 2023 Oct 23;14(1):6727. doi: 10.1038/s41467-023-42455-4.
Nat Commun. 2023.
PMID: 37872155
Free PMC article.
Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1.
Sugiyarto G, Lau D, Hill SL, Arcia-Anaya D, Boulanger DSM, Parkes E, James E, Elliott T.
Sugiyarto G, et al.
J Immunother Cancer. 2023 Aug;11(8):e007114. doi: 10.1136/jitc-2023-007114.
J Immunother Cancer. 2023.
PMID: 37586767
Free PMC article.
Item in Clipboard
Visualising tapasin- and TAPBPR-assisted editing of major histocompatibility complex class-I immunopeptidomes.
van Hateren A, Elliott T.
van Hateren A, et al.
Curr Opin Immunol. 2023 Aug;83:102340. doi: 10.1016/j.coi.2023.102340. Epub 2023 May 26.
Curr Opin Immunol. 2023.
PMID: 37245412
Free article.
Review.
Item in Clipboard
STAT5A antagonizes TOX in CD8+ T cell exhaustion.
Arcia-Anaya D, Elliott T.
Arcia-Anaya D, et al.
Nat Rev Immunol. 2023 Feb;23(2):73. doi: 10.1038/s41577-022-00833-x.
Nat Rev Immunol. 2023.
PMID: 36596846
No abstract available.
Item in Clipboard
Immunotherapy advances: One year on.
Elliott T.
Elliott T.
Immunother Adv. 2022 Jan 11;2(1):ltac001. doi: 10.1093/immadv/ltac001. eCollection 2022.
Immunother Adv. 2022.
PMID: 35919492
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite